Elaine is the Investment Director of Blue Sky Venture Capital and is responsible for the management of the Blue Sky venture capital fund and portfolio for Blue Sky. Established in 2012, the venture capital division has expanded to bear its second fund, VC2014, and over $40 million in assets under management across a broad range of industry sectors. Elaine has worked for a number of years as a venture capitalist and management consultant to the venture capital industry across Australia and the United States. As an Investment Manager at CM Capital Investments, a venture capital fund with $250 million under management and a dual focus on healthcare and digital technology, Elaine focused on investment origination, portfolio management as well as portfolio company performance. Elaine has also worked in strategic management consulting, with both NASDAQ and ASX listed and private companies based in Australia and the US. She developed a strong understanding of early stage investment, the unique operational, fiscal and commercial challenges early stage companies face, international markets, business cultures, in addition to building strong investment and industry networks, both domestically and internationally particularly in healthcare. Originally trained as a stem cell biologist, Elaine has since spent the last decade within the innovation and investment spectrum, initially in technology commercialisation assisting public institutions and founders translate and commercialise their technology across a broad range of industry sectors including agriculture, healthcare and IT. Following this, Elaine became the Chief Executive Officer of an early stage clinical diagnostics company where she reengineered the company’s commercialisation strategy, developed international partnerships for commercialisation and raised over $10 million dollars of venture capital, and public funding to support the Companys development.